en.Wedoany.com Reported - The latest episode of the European Coatings Podcast focuses on Carlyle's acquisition of Nouryon's polysulfide business, analyzing EU regulatory intervention, financial structure, and industry competition dynamics.

One of the key discussion points is the regulatory intervention by the European Commission. Comanita noted that the transaction was approved on the condition that Carlyle divest Nouryon's polysulfide business, setting a precedent indicating that regulators are increasingly scrutinizing portfolio overlaps of private equity firms—especially in the specialty chemicals sector, where the same sponsor may simultaneously control key raw material suppliers and downstream coating formulators. He also analyzed the strategic significance of the Qatar Investment Authority (QIA) as a co-investor, suggesting a deeper industrial connection related to sulfur raw materials for polysulfide chemicals.

The conversation delves into the financial structure of the deal: BASF retains a 40% stake while receiving €5.8 billion in cash. Comanita explained that this is a typical private equity strategy, reducing Carlyle's initial capital expenditure while providing BASF with a "second profit opportunity" through joint value creation in the future. Looking ahead, Comanita outlined Carlyle's near-term priorities, including establishing independent corporate functions, implementing equity-linked management incentive plans, and seizing market share opportunities while competitors such as AkzoNobel and Axalta remain focused on their own integration challenges.